Green light for new medicines
EMA Highlights by Gary Finnegan – The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended the granting of marketing authorisations for several new products.
EMA Highlights by Gary Finnegan – The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended the granting of marketing authorisations for several new products.
EMA Highlights by Gary Finnegan – The number of clinical trials taking place in Europe and North America continues to fall as research activity in Africa, Asia and… read more.
Abuse of common anesthetic has ‘rapid downhill course’, reports Journal of Addiction Medicine. Abuse of the anaesthesia drug propofol is a “rapidly progressive form of substance dependence” that… read more.
Advocates and pain management groups aired concerns recently over a citizen petition to change opioid labeling during the first of a 2-day FDA hearing.
Taken from the British Medical Journal (BMJ) – by Bruce Sylvester – Deaths and liver transplants related to paracetamol overdoses have decreased significantly due to UK legislation which… read more.
In a recent Clinical Crossroads article Dr. Dan Alford from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) suggests that prescription opioid abuse can be… read more.
EMA Highlights by Gary Finnegan – Pharmaceutical companies will have to pay more to have their new medicines evaluated, if the European Medicines Agency is to balance its… read more.
EMA Highlights by Gary Finnegan – Several new medicines have been approved by the EMA’s influential Committee for Medicinal Products for Human Use (CHMP), including the first non-surgical… read more.
EMA Highlights by Eoghan McNeill – The EMA has published revised guidelines on the evaluation of anti-cancer medicines to take account of advances in research and new therapeutic… read more.
Taken from the New England Journal of Medicine (NEJM) – by Bruce Sylvester – Ustekinumab, a drug used to treat psoriasis, appears to decrease the debilitating effects of… read more.
Taken from the New England Journal of Medicine (NEJM) – by Bruce Sylvester – Ustekinumab, a drug used to treat psoriasis, appears to decrease the debilitating effects of… read more.
Deliberately inflicting carefully controlled painful stimuli on human volunteers and seeing how well specific drugs reduce the feeling of pain can be an effective way of testing new… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.